May 07, 2018 12:01 pm UTC| Business
REDMOND, Wash., May 07, 2018 -- WorkBoard, a pioneer in Active Strategy Management™, is proud to announce integration of its flagship solution for intelligently setting, measuring and executing strategic priorities with...
Krystal Biotech Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 07, 2018 12:01 pm UTC| Business
IND for KB103 to treat dystrophic epidermolysis bullosa (DEB) cleared by FDA Patient enrollment in Phase 1/2 study of KB103 to begin in May 2018 at Stanford University Krystal Biotech’s KB103 receives Orphan Medicinal...
May 07, 2018 12:01 pm UTC| Business
FOR IMMEDIATE RELEASE Data presentation planned for first half of 2019 KNOXVILLE, TN, May 07, 2018 -- Provectus today announced the completion of enrollment of 24 patients with metastatic melanoma into the Phase...
Reputation.com to Host Transform 2018 Conference Series May 17-18
May 07, 2018 12:00 pm UTC| Business
REDWOOD CITY, Calif., May 07, 2018 -- Reputation.com, the first and only complete Online Reputation Management (ORM) platform for enterprise organizations, today announced its third annual conference series, Transform...
Green Plains Reports First Quarter 2018 Financial Results
May 07, 2018 12:00 pm UTC| Business
Company Launches Portfolio Optimization Program Net loss attributable to the company of $24.1 million, or $(0.60) per diluted shareEBITDA of $23.1 millionPortfolio Optimization Program to significantly reduce or...
CDTi Advanced Materials, Inc. Announces Timing of First Quarter 2018 Financial Results
May 07, 2018 12:00 pm UTC| Business
OXNARD, Calif., May 07, 2018 -- CDTi Advanced Materials, Inc., (Nasdaq:CDTI) (“CDTi” or “the Company”), a leader in advanced emission control technology, announced it will report its first quarter 2018 financial results...
May 07, 2018 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 07, 2018 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune...